Enthera
Milano
About Enthera
Enthera is a new Italian biotech start-up whose mission is to find new therapeutic approaches to treat diabetes and related gastrointestinal complication (enteropathy), as well as other intestinal disorders sharing the same biological pathway. Its name comes from the crasis of the terms entero (referring to the intestine) and therapy. Enthera was founded by BiovelocITA in October 2016 in collaboration with the scientists: Prof. Paolo Fiorina and Dr. Francesca D’Addio.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $46.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2021)
- Website: entherapharmaceuticals.com
- Phone: +39 02 3456778
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/enthera-34841 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.